Skip to main content
Fig. 6 | BMC Pharmacology and Toxicology

Fig. 6

From: Diminazene aceturate mitigates cardiomyopathy by interfering with renin-angiotensin system in a septic rat model

Fig. 6

Comparison of myocardial ACE (a), AT1R (b), ACE2 (c), and MasR (d) expressions among sham, CLP, and CLP + DIZE treatment groups (n = 6 rats/group). * P < 0.05 vs sham group; ** P < 0.01 vs sham group; # P < 0.05 vs CLP group. Abbreviations: CLP, cecal ligation and puncture; DIZE, diminazene aceturate; ACE, angiotensin-converting enzyme; AT1R, angiotensin type 1 receptor; ACE2, angiotensin-converting enzyme 2; MasR, Mas receptor

Back to article page

BMC Pharmacology and Toxicology

ISSN: 2050-6511

Contact us